European Viper Antivenom (2024) (Ангилья - Тендер #48592259) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Ангилья (другие тендеры и закупки Ангилья) Организатор тендера: Sell2Wales – Government´s Initiative Номер конкурса: 48592259 Дата публикации: 28-11-2023 Источник тендера: Sell2Wales – Government´s Initiative |
||
Results of the procurement procedure
Section I: Contracting entity I.1) Name and addressesSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
10 South Colonnade
London
E14 4PU
UK
Contact person: Alan White
E-mail: alan.white@ukhsa.gov.uk
NUTS: UKI42
Internet address(es)
Main address: https://www.gov.uk/government/organisations/uk-health-security-agency
Address of the buyer profile: https://www.gov.uk/government/organisations/uk-health-security-agency
I.2) Joint procurementThe contract is awarded by a central purchasing body
I.4) Type of the contracting authorityMinistry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activityHealth
Section II: Object II.1) Scope of the procurement II.1.1) TitleEuropean Viper Antivenom (2024)
Reference number: CM/PHV/24/152932
II.1.2) Main CPV code33600000
II.1.3) Type of contractSupplies
II.1.4) Short descriptionContract for the supply of European Viper Antivenom
II.1.6) Information about lotsThis contract is divided into lots: No
II.1.7) Total value of the procurementValue excluding VAT: 1.00 GBP
II.2) Description II.2.2) Additional CPV code(s)33600000
II.2.3) Place of performanceNUTS code:
UK
Main site or place of performance:
Lutterworth UK
II.2.4) Description of the procurementThe provision of European Viper Antivenom.<br/>Deliveries required over a two year period with an option for the Authority to extend for a period or periods up to an additional 24 months
II.2.5) Award criteriaQuality criterion: Comparison with Specification / Weighting: 30
Quality criterion: Risk to programme delivery / Weighting: 20
Quality criterion: Social value / Weighting: 10
Cost criterion: European Viper Antivenom price / Weighting: 40
II.2.11) Information about optionsOptions: Yes
Description of options:
The contract has the option to be extended for up to an additional 24 months
II.2.13) Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: No
II.2.14) Additional informationValue — The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.
Section IV: Procedure IV.1) Description IV.1.1) Type of procedureOpen procedure
IV.1.8) Information about Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: Yes
IV.2) Administrative information IV.2.1) Previous publication concerning this procedureNotice number in the OJ S:
2023/S 000-008938
Section V: Award of contractA contract/lot is awarded: Yes
V.2 Award of contract V.2.1) Date of conclusion of the contract08/11/2023
V.2.2) Information about tendersNumber of tenders received: 1
The contract has been awarded to a group of economic operators: No
V.2.3) Name and address of the contractorFLYNN PHARMA LTD
00210742
Hertlands House, Primett Road, Stevenage
Stevenage
SG1 3EE
UK
E-mail: commercialteam@flynnpharma.com
NUTS: UK
The contractor is an SME: No
V.2.4) Information on value of the contract/lot (excluding VAT)Initial estimated total value of the contract/lot:
Total value of the contract/lot: : 1.00 GBP
V.2.5) Information about subcontracting Section VI: Complementary information VI.3) Additional informationThe contract is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments and their executive agencies or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
VI.4) Procedures for review VI.4.1) Review bodyThe High Court
The Strand
London
WC2A 2LL
UK
Internet address(es)
URL: https://www.judiciary.uk/courts-and-tribunals/high-court/
VI.5) Date of dispatch of this notice27/11/2023
Information added to the notice since publication.
Additional information added to the notice since it"s publication.| No further information has been uploaded. |
| Main Contact: | alan.white@ukhsa.gov.uk |
| Admin Contact: | N/a |
| Technical Contact: | N/a |
| Other Contact: | N/a |
| ID | Title | Parent Category |
|---|---|---|
| 33600000 | Pharmaceutical products | Medical equipments, pharmaceuticals and personal care products |
| ID | Description |
|---|---|
| 100 | UK - All |
The buyer has restricted the alert for this notice to suppliers based in the following regions.
Alert Region Restrictions| There are no alert restrictions for this notice. |